Versor Investments’s Day One Biopharmaceuticals DAWN Stock Holding History

Versor Investments’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-123,673	Closed	-$2.65M	–	32
2026 Q1	$2.65M	Buy	+123,673	New	+$1.74M	6.49%	2

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Versor Investments's DAWN Position: Q2 2026 in Review

Versor Investments sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 123,673 shares — an estimated $2.65M sold.

Versor Investments first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $2.65M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Versor Investments reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Versor Investments sold 123,673 Day One Biopharmaceuticals shares in Q2 2026, an estimated $2.65M.
Versor Investments first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Versor Investments's Day One Biopharmaceuticals position peaked at $2.65M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Versor Investments's 13F filing for Q2 2026, filed 7 Aug 2026.